Multi-omics integration reveals a six-malignant cell maker gene signature for predicting prognosis in high-risk neuroblastoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Neuroinformatics"
DOI: 10.3389/fninf.2022.1034793
Abstract: Background Neuroblastoma is the most common extracranial solid tumor of childhood, arising from the sympathetic nervous system. High-risk neuroblastoma (HRNB) remains a major therapeutic challenge with low survival rates despite the intensification of therapy. This… read more here.
Keywords: malignant cell; cell; high risk; hrnb patients ... See more keywords